English | 简体中文 | 繁體中文 | 한국어 | 日本語
2017年3月15日 10時00分 JST
Share:
    

Source: Axiom Real-Time Metrics Inc.
Axiom Real-Time Metrics celebrates the expansion of its operations in Asia, and the establishment of its office in Beijing, China

TORONTO, ON, 2017年3月15日 - (JCN Newswire) - Axiom Real-Time Metrics, the premier provider of eClinical software solutions and services to small to mid-sized life sciences organizations, is celebrating the further expansion of its international footprint with the establishment of its office and team in Beijing, China.

Founded in 2001 with headquarters in Toronto, Canada, Axiom has operations in North America, Europe and Asia and clients with trials operating globally.

"Our office in Beijing has been up and running for one year supporting local clients. We now add key team members and representation in Business Development. This follows having resources in place in Hong Kong. Our continued investment in Asia represents our commitment to our clients in the region, and to the further expansion of our global services," shared Andrew Schachter, Founder and CEO.

"Catering to a global audience of leading life sciences organizations, our technology solutions offer benefits to our clients that we strongly believe are unmatched in our space. Our distinction of being Truly Unified is one that our clients understand, and is one which aligns with our Mission to do our part in enabling our clients to act at their fastest. For our clients, this means changing lives. We take our role very seriously and are proud of our accomplishments and the impact that we have had," stated Schachter.

"Our talented team in Beijing works very closely with our international team, and are a key part in ensuring we deliver unparalleled technology and service 24 hours a day, 365 days of the year," continued Schachter.

Axiom's office in Beijing is located in the Chaoyang District and offers room for growth and space for client meetings and onsite training.

About Axiom Real-Time Metrics

Headquartered in Toronto, Canada, Axiom delivers intuitive, powerful and cost-effective eClinical solutions and services focused around your entire study. Services include: DM, Biostatistics and Pharmacovigilance. Axiom's eClinical suite, Fusion, delivers a powerful range of innovative end-user focused, unified functionality and 15 modules. Fusion Delivers: EDC, DM, IWRS, CTMS, Inventory Management, IVR, Patient Portal, AE/SAE Tracking, Safety Database, Central Lab, Imaging, eTMF, and 24/7 Project and Clinical Data Reporting. For more information, please visit http://www.axiommetrics.com/

Contact
solutions@axiom.cc
+1.877.321.9191

PR Contact
Sarah Glofcheskie
sarahg@axiom.cc
+1.647.588.9073

配信代行: JCN

トピック: Press release summary
Source: Axiom Real-Time Metrics Inc.


https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Ordify Employs Blockpass to Open Investment to Everyone  
May 3, 2024 13:38 HKT/SGT
SDAI Limited: Positive Outcomes Since New Board took over in June 2023 
May 2, 2024 21:00 HKT/SGT
CleverTap launches Clever.AI, the AI-Driven Edge for Customer Engagement & Retention 
May 2, 2024 18:00 HKT/SGT
韓国1位の成人教育分野企業のファストキャンパス、日本への新事業参入に本格化 
May 2, 2024 13:00 HKT/SGT
JuicyBet Launches Its Innovative GambleFi Platform 
May 2, 2024 11:00 HKT/SGT
住友金属鉱山と三菱商事、豪州カルグーリー・ニッケル・プロジェクト グーンガリー・ハブの事業化調査・新規参画について 
Apr 30, 2024 17:00 HKT/SGT
GAMELIGHT はJOYCITYのために日本と韓国で257%、英国で230%のROAS D7からD30成長を達成ーケーススタディ 
Apr 30, 2024 10:00 HKT/SGT
UK advertising reports GBP36.6bn spend in 2023 
Apr 26, 2024 18:30 HKT/SGT
Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project 
Apr 26, 2024 14:34 HKT/SGT
スパークス・グループによる「宇宙フロンティア2号ファンド」の設立について 
Apr 26, 2024 14:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575